Organization · Venture Capital
Carbon Silicon Ventures
Carbon Silicon Ventures is an early-stage venture capital firm based in the USA, focusing on biotechnology and life sciences. They invest in innovative companies that apply engineering principles to biology.
Overview
What Carbon Silicon Ventures does
What Carbon Silicon Ventures is
Carbon Silicon Ventures is an early-stage venture capital firm based in the USA, focusing on biotechnology and life sciences. They invest in innovative companies that apply engineering principles to biology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Carbon Silicon Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Carbon Silicon Ventures as a funder
Investment thesis
Carbon Silicon Ventures backs technical founders applying engineering rigor to biology, transforming biology into an engineering discipline.
Focus narrative
Carbon Silicon Ventures invests in biotechnology and life sciences companies at various stages of development. The firm focuses on sectors related to drug delivery, protein design, RNA therapeutics, and other biotechnological advancements, seeking to back founders who are transforming biology into a more systematic and scalable discipline.
Value beyond capital
Carbon Silicon Ventures provides strategic support to its portfolio companies by leveraging its expertise in biotechnology and life sciences. The firm focuses on enabling founders with technical backgrounds and aims to facilitate the development of innovative solutions that fundamentally change how biological work is conducted.
Terms and economics
- Typical check
- $100,000–$500,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- United States · North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 11
- Recorded notable exits
- Sphinx Bio
Portfolio context
Notable portfolio companies include: Ansa Biotechnologies: Enzymatic DNA synthesis platform. Octant: Engineering multi-target corrector molecules. Basepair: Bioinformatics and genomic data management infrastructure. Medra AI: Physical AI Scientist for biological data collection. Femtofluidics: Digital microfluidics platform for high-throughput assays. Bluenote Health: AI platform for regulatory workflows in life sciences. Tetsuwan Scientific: Autonomous AI scientist and lab automation. Current Surgical: Smart surgical needle for tumor ablation.
Common questions
What to know about Carbon Silicon Ventures
Upseed classifies Carbon Silicon Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.